U.S. Patent Disclosures
Thursday, May 12, 2011
Salix Pharmaceuticals Ltd., of Raleigh, N.C., received U.S. Patent No. 7,928,115, which covers methods of treating travelers' diarrhea with rifaximin.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.